Cellular Superspreaders: An Epidemiological Perspective on HIV Infection inside the Body

PLoS Pathogens

Volumn 10, Issue 5, 2014, Pages

  Talbert Slagle, Kristina ^a   Atkins, Katherine E ^a   Yan, Koon Kiu ^a   Khurana, Ekta ^a   Gerstein, Mark ^a   Bradley, Elizabeth H ^a   Berg, David ^a,b   Galvani, Alison P ^a   Townsend, Jeffrey P ^a  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTACT EXAMINATION; CYTOLOGY; DISEASE CARRIER; FEMALE; FEMALE GENITAL SYSTEM; HETEROZYGOTE; HIV INFECTIONS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; MUCOSA; PHYSIOLOGY; SEXUAL BEHAVIOR; STATISTICS AND NUMERICAL DATA; TRANSMISSION; VIROLOGY; VIRUS SHEDDING;

CARRIER STATE; CONTACT TRACING; DISEASE RESERVOIRS; FEMALE; GENITALIA, FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MUCOUS MEMBRANE; SEXUAL BEHAVIOR; VIRUS SHEDDING;

EID: 84901655581     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004092     Document Type: Article

References (96)

1. UNAIDS (2013) Global Report: UNAIDS report on the global AIDS epidemic 2013. 2013 edition. Online: Joint United Nations Programme on HIV/AIDS. Available: http://www.unaids.org/en/resources/campaigns/globalreport2013/globalreport/. Accessed 7 April 2014.
2. Boily MC, Baggaley RF, Wang L, Masse B, White RG, et al. (2009) Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 9: 118-129.
3. Keele BF, Estes JD, (2011) Barriers to mucosal transmission of immunodeficiency viruses. Blood 118: 839-846.
4. Li H, Bar KJ, Wang S, Decker JM, Chen Y, et al. (2010) High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. PLoS Pathog 6: e1000890.
5. Parrish NF, Gao F, Li H, Giorgi EE, Barbian HJ, et al. (2013) Phenotypic properties of transmitted founder HIV-1. Proc Natl Acad Sci U S A 110: 6626-6633.
6. Raj A, van Oudenaarden A, (2008) Nature, nurture, or chance: stochastic gene expression and its consequences. Cell 135: 216-226.
7. Sallusto F, Lanzavecchia A, (2009) Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity. Eur J Immunol 39: 2076-2082.
8. Reilly C, Schacker T, Haase AT, Wietgrefe S, Krason D, (2002) The Clustering of Infected SIV Cells in Lymphatic Tissue. J Am Stat Assoc 97: 943-954.
9. Li Q, Estes JD, Schlievert PM, Duan L, Brosnahan AJ, et al. (2009) Glycerol monolaurate prevents mucosal SIV transmission. Nature 458: 1034-1038.
10. Zhang ZQ, Wietgrefe SW, Li Q, Shore MD, Duan L, et al. (2004) Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection. Proc Natl Acad Sci U S A 101: 5640-5645.
11. Zhu J, Paul WE, (2010) Heterogeneity and plasticity of T helper cells. Cell Res 20: 4-12.
12. Altschuler SJ, Wu LF, (2010) Cellular heterogeneity: do differences make a difference? Cell 141: 559-563.
13. McKinnon LR, Kaul R, (2012) Quality and quantity: mucosal CD4+ T cells and HIV susceptibility. Curr Opin HIV AIDS 7: 195-202.
14. Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM, (2005) Superspreading and the effect of individual variation on disease emergence. Nature 438: 355-359.
15. Anderson RM, May RM (1991) Infectious diseases of humans: dynamics and control. New York: Oxford University Press.
16. Keeling MJ, Rohani P (2008) Modeling infectious diseases in humans and animals. Princeton: Princeton University Press. xi, 366 pp.
17. De Serres G, Markowski F, Toth E, Landry M, Auger D, et al. (2013) Largest measles epidemic in North America in a decade-Quebec, Canada, 2011: contribution of susceptibility, serendipity, and superspreading events. J Infect Dis 207: 990-998.
18. Stein RA, (2011) Super-spreaders in infectious diseases. Int J Infect Dis 15: e510-513.
19. Centers for Disease Control and Prevention (2003) Severe acute respiratory syndrome-Singapore, 2003. MMWR Morb Mortal Wkly Rep 52: 405-411.
20. Ribeiro RM, Qin L, Chavez LL, Li D, Self SG, et al. (2010) Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection. J Virol 84: 6096-6102.
21. Anderson D, Politch JA, Pudney J, (2011) HIV infection and immune defense of the penis. Am J Reprod Immunol 65: 220-229.
22. Liu A, Yang Y, Liu L, Meng Z, Li L, et al. (2014) Differential Compartmentalization of HIV-Targeting Immune Cells in Inner and Outer Foreskin Tissue. PLoS One 9: e85176.
23. Patterson BK, Landay A, Siegel JN, Flener Z, Pessis D, et al. (2002) Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am J Pathol 161: 867-873.
24. Saba E, Grivel JC, Vanpouille C, Brichacek B, Fitzgerald W, et al. (2010) HIV-1 sexual transmission: early events of HIV-1 infection of human cervico-vaginal tissue in an optimized ex vivo model. Mucosal Immunol 3: 280-290.
25. McKinnon LR, Nyanga B, Chege D, Izulla P, Kimani M, et al. (2011) Characterization of a human cervical CD4+ T cell subset coexpressing multiple markers of HIV susceptibility. J Immunol 187: 6032-6042.
26. Grivel JC, Elliott J, Lisco A, Biancotto A, Condack C, et al. (2007) HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1. AIDS 21: 1263-1272.
27. Pudney J, Quayle AJ, Anderson DJ, (2005) Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod 73: 1253-1263.
28. Strain MC, Richman DD, Wong JK, Levine H, (2002) Spatiotemporal dynamics of HIV propagation. J Theor Biol 218: 85-96.
29. Snijder B, Sacher R, Ramo P, Damm EM, Liberali P, et al. (2009) Population context determines cell-to-cell variability in endocytosis and virus infection. Nature 461: 520-523.
30. Snijder B, Sacher R, Ramo P, Liberali P, Mench K, et al. (2012) Single-cell analysis of population context advances RNAi screening at multiple levels. Mol Syst Biol 8: 579.
31. Zhong P, Agosto LM, Munro JB, Mothes W, (2013) Cell-to-cell transmission of viruses. Curr Opin Virol 3: 44-50.
32. Sagar M, (2010) HIV-1 transmission biology: selection and characteristics of infecting viruses. J Infect Dis 202 Suppl 2: S289-296.
33. Lee B, Sharron M, Montaner LJ, Weissman D, Doms RW, (1999) Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A 96: 5215-5220.
34. Chen J, Dang Q, Unutmaz D, Pathak VK, Maldarelli F, et al. (2005) Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor. J Virol 79: 4140-4149.
35. Kabat D, Kozak SL, Wehrly K, Chesebro B, (1994) Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1. J Virol 68: 2570-2577.
36. Parker ZF, Iyer SS, Wilen CB, Parrish NF, Chikere KC, et al. (2013) Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5. J Virol 87: 2401-2411.
37. Johnston SH, Lobritz MA, Nguyen S, Lassen K, Delair S, et al. (2009) A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains. J Virol 83: 11016-11026.
38. Bozek K, Eckhardt M, Sierra S, Anders M, Kaiser R, et al. (2012) An expanded model of HIV cell entry phenotype based on multi-parameter single-cell data. Retrovirology 9: 60.
39. Arthos J, Cicala C, Martinelli E, Macleod K, Van Ryk D, et al. (2008) HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat Immunol 9: 301-309.
40. Cicala C, Martinelli E, McNally JP, Goode DJ, Gopaul R, et al. (2009) The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proc Natl Acad Sci U S A 106: 20877-20882.
41. Harris RS, Hultquist JF, Evans DT, (2012) The restriction factors of human immunodeficiency virus. J Biol Chem 287: 40875-40883.
42. Wang X, Abudu A, Son S, Dang Y, Venta PJ, et al. (2011) Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity. J Virol 85: 3142-3152.
43. Mous K, Jennes W, De Roo A, Pintelon I, Kestens L, et al. (2011) Intracellular detection of differential APOBEC3G, TRIM5alpha, and LEDGF/p75 protein expression in peripheral blood by flow cytometry. J Immunol Methods 372: 52-64.
44. Pan X, Baldauf HM, Keppler OT, Fackler OT, (2013) Restrictions to HIV-1 replication in resting CD4(+) T lymphocytes. Cell Res 23: 876-885.
45. Marquardt A, Halle S, Seckert CK, Lemmermann NA, Veres TZ, et al. (2011) Single cell detection of latent cytomegalovirus reactivation in host tissue. J Gen Virol 92: 1279-1291.
46. Weinberger LS, Burnett JC, Toettcher JE, Arkin AP, Schaffer DV, (2005) Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity. Cell 122: 169-182.
47. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, et al. (2002) HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110: 521-529.
48. Mitchell RS, Beitzel BF, Schroder AR, Shinn P, Chen H, et al. (2004) Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2: e234.
49. Wu X, Li Y, Crise B, Burgess SM, (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science 300: 1749-1751.
50. Skupsky R, Burnett JC, Foley JE, Schaffer DV, Arkin AP, (2010) HIV promoter integration site primarily modulates transcriptional burst size rather than frequency. PLoS Comput Biol 6: e1000952.
51. Josefsson L, Palmer S, Faria NR, Lemey P, Casazza J, et al. (2013) Single cell analysis of lymph node tissue from HIV-1 infected patients reveals that the majority of CD4+ T-cells contain one HIV-1 DNA molecule. PLoS Pathog 9: e1003432.
52. Jung A, Maier R, Vartanian JP, Bocharov G, Jung V, et al. (2002) Recombination: Multiply infected spleen cells in HIV patients. Nature 418: 144.
53. Haigwood NL, (2009) Update on animal models for HIV research. Eur J Immunol 39: 1994-1999.
54. Pan LZ, Werner A, Levy JA, (1993) Detection of plasma viremia in human immunodeficiency virus-infected individuals at all clinical stages. J Clin Microbiol 31: 283-288.
55. Miller CJ, Marthas M, Torten J, Alexander NJ, Moore JP, et al. (1994) Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J Virol 68: 6391-6400.
56. El Hed A, Khaitan A, Kozhaya L, Manel N, Daskalakis D, et al. (2010) Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. J Infect Dis 201: 843-854.
57. Monteiro P, Gosselin A, Wacleche VS, El-Far M, Said EA, et al. (2011) Memory CCR6+CD4+ T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin beta7. J Immunol 186: 4618-4630.
58. Alvarez Y, Tuen M, Shen G, Nawaz F, Arthos J, et al. (2013) Preferential HIV infection of CCR6+ Th17 cells is associated with higher levels of virus receptor expression and lack of CCR5 ligands. J Virol 87: 10843-10854.
59. Shaw GM, Hunter E, (2012) HIV transmission. Cold Spring Harb Perspect Med 2: a006965.
60. Dahabieh MS, Ooms M, Simon V, Sadowski I, (2013) A double-fluorescent HIV-1 reporter shows that the majority of integrated HIV-1 is latent shortly after infection. J Virol 87: 4716-4727.
61. Duverger A, Jones J, May J, Bibollet-Ruche F, Wagner FA, et al. (2009) Determinants of the establishment of human immunodeficiency virus type 1 latency. J Virol 83: 3078-3093.
62. Miller CJ, Li Q, Abel K, Kim EY, Ma ZM, et al. (2005) Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol 79: 9217-9227.
63. McChesney MB, Collins JR, Lu D, Lu X, Torten J, et al. (1998) Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV. J Virol 72: 10029-10035.
64. Ma ZM, Abel K, Rourke T, Wang Y, Miller CJ, (2004) A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations. J Virol 78: 14048-14052.
65. Beyrer C, Artenstein AW, Rugpao S, Stephens H, VanCott TC, et al. (1999) Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group. J Infect Dis 179: 59-67.
66. Kaul R, Rowland-Jones SL, Kimani J, Fowke K, Dong T, et al. (2001) New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. Immunol Lett 79: 3-13.
67. Horton RE, Ball TB, Wachichi C, Jaoko W, Rutherford WJ, et al. (2009) Cervical HIV-specific IgA in a population of commercial sex workers correlates with repeated exposure but not resistance to HIV. AIDS Res Hum Retroviruses 25: 83-92.
68. Uberla K, (2008) HIV vaccine development in the aftermath of the STEP study: re-focus on occult HIV infection? PLoS Pathog 4: e1000114.
69. Go EP, Hewawasam G, Liao HX, Chen H, Ping LH, et al. (2011) Characterization of glycosylation profiles of HIV-1 transmitted/founder envelopes by mass spectrometry. J Virol 85: 8270-8284.
70. Gnanakaran S, Bhattacharya T, Daniels M, Keele BF, Hraber PT, et al. (2011) Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections. PLoS Pathog 7: e1002209.
71. Nawaz F, Cicala C, Van Ryk D, Block KE, Jelicic K, et al. (2011) The genotype of early-transmitting HIV gp120s promotes alpha (4) beta(7)-reactivity, revealing alpha (4) beta(7) +/CD4+ T cells as key targets in mucosal transmission. PLoS Pathog 7: e1001301.
72. Pena-Cruz V, Etemad B, Chatziandreou N, Nyein PH, Stock S, et al. (2013) HIV-1 envelope replication and alpha4beta7 utilization among newly infected subjects and their corresponding heterosexual partners. Retrovirology 10: 162.
73. Etemad B, Gonzalez OA, McDonough S, Pena-Cruz V, Sagar M, (2013) Early infection HIV-1 envelope V1-V2 genotypes do not enhance binding or replication in cells expressing high levels of alpha4beta7 integrin. J Acquir Immune Defic Syndr 64: 249-253.
74. Redd AD, Collinson-Streng AN, Chatziandreou N, Mullis CE, Laeyendecker O, et al. (2012) Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions. J Infect Dis 206: 1433-1442.
75. Parrish NF, Wilen CB, Banks LB, Iyer SS, Pfaff JM, et al. (2012) Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin alpha4beta7. PLoS Pathog 8: e1002686.
76. Mota TM, Murray JM, Center RJ, Purcell DF, McCaw JM, (2012) Application of a case-control study design to investigate genotypic signatures of HIV-1 transmission. Retrovirology 9: 54.
77. Shen C, Ding M, Ratner D, Montelaro RC, Chen Y, et al. (2012) Evaluation of cervical mucosa in transmission bottleneck during acute HIV-1 infection using a cervical tissue-based organ culture. PLoS One 7: e32539.
78. Ochsenbauer C, Edmonds TG, Ding H, Keele BF, Decker J, et al. (2012) Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages. J Virol 86: 2715-2728.
79. Pearson JE, Krapivsky P, Perelson AS, (2011) Stochastic theory of early viral infection: continuous versus burst production of virions. PLoS Comput Biol 7: e1001058.
80. Zhang Z, Schuler T, Zupancic M, Wietgrefe S, Staskus KA, et al. (1999) Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 286: 1353-1357.
81. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD, (1996) HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271: 1582-1586.
82. Archin NM, Vaidya NK, Kuruc JD, Liberty AL, Wiegand A, et al. (2012) Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection. Proc Natl Acad Sci U S A 109: 9523-9528.
83. Haase AT, (2011) Early events in sexual transmission of HIV and SIV and opportunities for interventions. Annu Rev Med 62: 127-139.
84. Funderburg NT, Stubblefield Park SR, Sung HC, Hardy G, Clagett B, et al. (2013) Circulating CD4(+) and CD8(+) T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammation. Immunology 140: 87-97.
85. Chowell G, Hengartner NW, Castillo-Chavez C, Fenimore PW, Hyman JM, (2004) The basic reproductive number of Ebola and the effects of public health measures: the cases of Congo and Uganda. J Theor Biol 229: 119-126.
86. Khan AS, Tshioko FK, Heymann DL, Le Guenno B, Nabeth P, et al. (1999) The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 179 Suppl 1: S76-86.
87. Christensen PE, Schmidt H, Bang HO, Andersen V, Jordal B, et al. (1953) An epidemic of measles in southern Greenland, 1951; measles in virgin soil. II. The epidemic proper. Acta Med Scand 144: 430-449.
88. Chen RT, Goldbaum GM, Wassilak SG, Markowitz LE, Orenstein WA, (1989) An explosive point-source measles outbreak in a highly vaccinated population. Modes of transmission and risk factors for disease. Am J Epidemiol 129: 173-182.
89. Gani R, Leach S, (2004) Epidemiologic determinants for modeling pneumonic plague outbreaks. Emerg Infect Dis 10: 608-614.
90. Tieh TH, Landauer E, et al. (1948) Primary pneumonic plague in Mukden, 1946, and report of 39 cases with three recoveries. J Infect Dis 82: 52-58.
91. Bauch CT, Lloyd-Smith JO, Coffee MP, Galvani AP, (2005) Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future. Epidemiology 16: 791-801.
92. Yu IT, Li Y, Wong TW, Tam W, Chan AT, et al. (2004) Evidence of airborne transmission of the severe acute respiratory syndrome virus. N Engl J Med 350: 1731-1739.
93. Kamps BS, Hoffmann C, editors (2005) SARS Reference. 3rd edition. Flying Publisher.
94. Varia M, Wilson S, Sarwal S, McGeer A, Gournis E, et al. (2003) Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. CMAJ 169: 285-292.
95. Gani R, Leach S, (2001) Transmission potential of smallpox in contemporary populations. Nature 414: 748-751.
96. Fenner F (1988) Smallpox and its eradication. Geneva: World Health Organization. xvi, 1460 pp.